Mission & Vision
We’re advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.
Our Novel Platform
Introducing our novel platform for neurodegenerative disease
Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease.
Leveraging our platform across multiple neurodegenerative diseases.
MCI - Alzheimer’s Disease
Parkinson’s Disease - Dementia
Latest News & Updates
Stay up to date
Jan 20, 2023
The promising new Alzheimer's drugs to watch — and the far-out ideas that could reshape how we treat the disease
Dec 1, 2022
Startup’s Headset to Treat Alzheimer’s Will Undergo Wide Trial With Patients
Aug 3, 2022
Cognito's light-and-sound therapy slows brain tissue atrophy in Alzheimer's study
May 2, 2022